Staff members (REF1a/c)
1 - Clinical Medicine
University of Leeds
- A - Cancer
- A - Cancer
- A - Cancer
- D - Cardiovascular
- A - Cancer
- C - Musculoskeletal
- A - Cancer
- B - Genes and Development
- C - Musculoskeletal
Marzo-Ortega is an Honorary Clinical Associate Professor within the Leeds Institute of Rheumatic and Musculoskeletal Medicine at the University of Leeds. She is the Spondyloarthropathy Service Clinical Lead and her academic activity is focussed on translational research, working closely with UoA1 returnees (McGonagle, Emery, Conaghan, O’Connor, Grainger, Bennett and Morgan). Her main areas of interest are within the field of early arthritis, undifferentiated arthritis and the spondyloarthritides, including psoriatic arthritis (PsA) and ankylosing spondylitis (AS), focussing on biologic therapies and imaging and molecular biomarkers. In the UK, she has been a member of the BSR working group for guidelines in the use of biologic drugs in AS since 2004 and is currently working on the 2013 guidelines update. She has 120 publications (H-index 22) with 50 in the last 5 years, with all 50 being co-authored with the aforementioned UoA1 returnees.
- C - Musculoskeletal
- C - Musculoskeletal
- A - Cancer
- B - Genes and Development
- C - Musculoskeletal
- A - Cancer
- C - Musculoskeletal
O’Connor is an expert musculoskeletal radiologist, who is the Director or the LMBRU Imaging Centre and an Honorary Clinical Associate Professor within the Leeds Institute of Rheumatic and Musculoskeletal Medicine at the University of Leeds. O’Connor has worked closely with his rheumatology colleagues returned in UoA1 (Emery, Conaghan, McGonagle, Wakefield, Grainger) developing their interest and utilisation of musculoskeletal imaging, particularly biomarker development utilizing MR and ultrasound. O’Connor is a Fellow of the Faculty of Sport and Exercise Medicine UK, has extensive professional sports experience and led the imaging service for the 2012 Olympics. He is widely published, with over 120 peer reviewed publications (H-index of 38), 27 in the last 5 years (17 with aforementioned UoA1 returnees).
- A - Cancer
- A - Cancer
- D - Cardiovascular
- B - Genes and Development
- D - Cardiovascular
- C - Musculoskeletal
- D - Cardiovascular
- D - Cardiovascular
- A - Cancer
- A - Cancer
- A - Cancer
- A - Cancer
Rawstron is an Honorary Research Fellow with the University and an NHS clinical scientist with a research interest in haematological malignancies.
Throughout the REF period Rawstron has worked in the Haematological Malignancy Diagnostic Service that supports clinical services and research by University of Leeds colleagues returned in REF UOA1 (Cook, Hillmen), and NHS colleagues (including Bowen; Category C).
Rawston has a distinguished academic record, with more than 40 papers listed on PubMed in the last 5 years, of which 16 were co-authored with University of Leeds UOA1 returnees in Cancer Research (Cook, Doody, Hillmen, Selby, Tooze; all Category A) and Musculoskeletal Research (Buch, Emery; Category A).
Rawstron's work into the understanding of chronic lymphocytic leukaemia (CLL), both in terms of defining the nature of Monoclonal B-Lymphocytosis and in developing and standardizing the assessment of minimal residual disease (MRD) in CLL, is internationally recognized.
- A - Cancer
- C - Musculoskeletal
- C - Musculoskeletal
Dr Saleem undertook a MD at the University of Leeds in the Leeds Institute of Rheumatic and Musculoskeletal Medicine and was supervised by Emery and Ponchel. She retains an Honorary Research Fellow position at the University of Leeds. She was directly responsible for the trial design, writing of protocol, recruitment of patients, analysis of data and publication of results. The focus of her research was analysis of remission in rheumatoid arthritis. As a consequence of this work a database has been established that has allowed ongoing analysis and collaborations with the Leeds Institute of Rheumatic and Musculoskeletal Medicine. She continues to work closely with Emery and Ponchel, both in terms of future remission studies and publications, with 11 papers co-authored with University of Leeds UoA1 returnees (Emery, Ponchel, Buch, Wakefield, Conaghan) in the last 5 years. The recruitment of patients in York for multi-centre studies led by Leeds is central to the inflammatory arthritis work currently undertaken in Leeds.
- C - Musculoskeletal
Savic is an Honorary Clinical Associate Professor working within the Leeds Institute of Rheumatic and Musculoskeletal Medicine at the University of Leeds and a member of NIHR-Leeds Musculoskeletal Biomedical Research Unit.
Savic is co-supervising Industry and AR-UK-funded projects with UoA1 returnees (McDermott, Emery, Ponchel, Morgan and Robinson) to validate the utility of novel cellular biomarker assays in predicting disease progression in the early RA and investigation of the effects of metabolic and cellular stress on pathogenesis of RA. He has facilitated introduction of research grade assays into the routine NHS diagnostic immunology laboratory in Leeds.
His other research interests include molecular pathogenesis of inflammation in primary immunodeficiencies, autoinflammatory conditions such as rare periodic fever syndromes (McDermott) and immunomodulatory role of intravenous immunoglobiulin therapy (Robinson, Morgan). He has published 15 papers in the last 5 years with UoA1 returnees (McDermott, Emery, McGonagle, Wittmann, Morgan and Robinson).
- A - Cancer
- A - Cancer
- A - Cancer
- B - Genes and Development
- A - Cancer
- A - Cancer
- D - Cardiovascular
- B - Genes and Development
- C - Musculoskeletal
- C - Musculoskeletal
- A - Cancer
- A - Cancer
- B - Genes and Development
- A - Cancer
- A - Cancer
- A - Cancer
- A - Cancer
- A - Cancer